Astrana Health EBITDA 2016-2026 | ASTH
Astrana Health ebitda from 2016 to 2026. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
Astrana Health Annual EBITDA (Millions of US $) |
|
|---|---|
| 2025 | $128 |
| 2024 | $119 |
| 2023 | $103 |
| 2022 | $123 |
| 2021 | $117 |
| 2020 | $100 |
| 2019 | $53 |
| 2018 | $112 |
| 2017 | $57 |
| 2017 | $-10 |
| 2016 | $30 |
| 2016 | $-7 |
| 2015 | $-17 |
| 2015 | $0 |
| 2014 | $0 |
|
Astrana Health Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2026-06-30 | $51 |
| 2026-03-31 | $45 |
| 2025-12-31 | $36 |
| 2025-09-30 | $36 |
| 2025-06-30 | $28 |
| 2025-03-31 | $28 |
| 2024-12-31 | $9 |
| 2024-09-30 | $36 |
| 2024-06-30 | $38 |
| 2024-03-31 | $36 |
| 2023-12-31 | $1 |
| 2023-09-30 | $44 |
| 2023-06-30 | $32 |
| 2023-03-31 | $27 |
| 2022-12-31 | $17 |
| 2022-09-30 | $55 |
| 2022-06-30 | $20 |
| 2022-03-31 | $31 |
| 2021-12-31 | $7 |
| 2021-09-30 | $58 |
| 2021-06-30 | $26 |
| 2021-03-31 | $26 |
| 2020-12-31 | $31 |
| 2020-09-30 | $42 |
| 2020-06-30 | $18 |
| 2020-03-31 | $9 |
| 2019-12-31 | $16 |
| 2019-09-30 | $17 |
| 2019-06-30 | $19 |
| 2019-03-31 | $1 |
| 2018-12-31 | $10 |
| 2018-09-30 | $61 |
| 2018-06-30 | $12 |
| 2018-03-31 | $28 |
| 2017-12-31 | $27 |
| 2017-09-30 | $26 |
| 2017-06-30 | $9 |
| 2017-03-31 | $21 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.138B | $3.182B |
| Astrana Health is a provider-centric, technology-powered healthcare company. It operates an integrated healthcare delivery platform which enables providers to participate in value-based care arrangements. Astrana Health, formerly known as Apollo Medical Holdings Inc., is based in ALHAMBRA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |